Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2003-12-22
2008-08-05
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S266300, C544S243000, C544S244000, C544S284000
Reexamination Certificate
active
07407946
ABSTRACT:
Quinazoline derivatives of formula (I) wherein A is 5-membered heteroaryl containing a sulphur atom and optionally containing one or more nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.
REFERENCES:
patent: 6919338 (2005-07-01), Mortlock et al.
patent: 2006/0058325 (2006-03-01), Mortlock
patent: 2006/0116357 (2006-06-01), Heron et al.
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 02/00649 (2002-01-01), None
patent: WO 03/000188 (2003-01-01), None
Bischoff, J.R. et. al., “A homologue ofDrosophila aurorakinase . . . ”, The EMBO Journal, 1998, vol. 17, No. 11, pp. 3052-3065.
AstraZeneca AB
Truong Tamthom N
Wilson James O.
LandOfFree
Quinazoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4005404